Dated : 11th April, 2002
The National Pharmaceutical Pricing Authority has revised/fixed the prices of 16 formulation packs on April 10, 2002. In the case of 12 packs, prices have been increased ranging from 5.13% to 19.63%. Of the 16 formulation packs, ceiling prices have been fixed in respect of 3 packs and for rest 13 packs non-ceiling price have been fixed. The formulations for which prices have been fixed/ revised include formulations based on bulk drugs Pyrantel Pamoate, Insulin and Ephedrine. These formulations are used in various treatments/ diseases like anti-helminthics, diabetes and ashtamaic disorders etc.
For details please click the following:
- Copy of Press Release/Explanatory Note
- Copy of Statement (for details of existing and revised prices).
- Ceiling Price
| S.No | S.O.No | Date | Formulations based on |
|---|---|---|---|
| a. | 400(E) | 10-4-2002 | Pyrantel Pamoate |
- Non Ceiling Prices
| Sl. No. | Company Name | Product Name |
| (i) | Eli Lilly and Company (I) Pvt. Ltd. | Monocomponent Insulin |
| (ii) | M.J. Pharmaceuticals Ltd. | Huminsulin NPH/ Human Insulin |
| (iii) | Nicholas Piramal (I) Ltd. | Asmapax Depot |
| (iv) | Novo-Nordisk (I) Pvt. Ltd. | Actrapid HM Vials/ Monotard HM/ Mixtard HM/ Actrapid HM Penfill/ Mixtard HM Penfill/ Insulatard HM Penfill |
(Dr. P.V. Appaji)
Director
Last Page Updated: 31-05-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)